SLQT Stock Overview
Operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
SelectQuote, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$3.24 |
52 Week High | US$4.46 |
52 Week Low | US$1.03 |
Beta | 1.07 |
11 Month Change | 3.51% |
3 Month Change | 13.68% |
1 Year Change | 138.24% |
33 Year Change | -76.57% |
5 Year Change | n/a |
Change since IPO | -88.00% |
Recent News & Updates
Recent updates
SelectQuote, Inc. (NYSE:SLQT) Doing What It Can To Lift Shares
Jul 02Investors Still Aren't Entirely Convinced By SelectQuote, Inc.'s (NYSE:SLQT) Revenues Despite 29% Price Jump
Feb 13SelectQuote Q2: Strong Revenue Growth But Retaining My Hold Rating
Feb 07SelectQuote: Insider Buying But A Significant Debt Load
Nov 13It's Probably Less Likely That SelectQuote, Inc.'s (NYSE:SLQT) CEO Will See A Huge Pay Rise This Year
Nov 08SelectQuote: Still Risky After Falling 96% From Its Peak
Sep 01Market Cool On SelectQuote, Inc.'s (NYSE:SLQT) Revenues Pushing Shares 29% Lower
Aug 25SelectQuote's Focus On Profitability Is Beginning To Show
Jun 08SelectQuote appoints Ryan Clement as CFO
Feb 22SelectQuote Q2 2023 Earnings Preview
Feb 06SelectQuote Q1 2023 Earnings Preview
Nov 02NYSE notifies SelectQuote of non-compliance
Oct 27SelectQuote: Skeptical About The Turnaround Plan
Sep 13SelectQuote appoints Alan Muney as chief medical officer
Aug 25SelectQuote: The Retrenching Plan May Not Work Out
May 25SelectQuote: This Did Not Turn Out As Planned
Feb 22SelectQuote Appears Well Positioned For All-Important Q4
Dec 03SelectQuote: Ignore Sentiment, And Stick To Fundamentals
Nov 18SelectQuote: Sizing Up This Volatile Insurance Broker
Oct 10The Bottom Fishing Club: SelectQuote
Sep 06SelectQuote: Underappreciated Growth Story
Jul 21LexinFintech leads week's biggest financial gainers, while Credit Acceptance declines
Jun 04Shareholder Returns
SLQT | US Insurance | US Market | |
---|---|---|---|
7D | -12.0% | -0.5% | -3.4% |
1Y | 138.2% | 34.2% | 19.6% |
Return vs Industry: SLQT exceeded the US Insurance industry which returned 34.2% over the past year.
Return vs Market: SLQT exceeded the US Market which returned 19.6% over the past year.
Price Volatility
SLQT volatility | |
---|---|
SLQT Average Weekly Movement | 11.8% |
Insurance Industry Average Movement | 4.1% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.1% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SLQT's share price has been volatile over the past 3 months.
Volatility Over Time: SLQT's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 4,186 | Tim Danker | www.selectquote.com |
SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
SelectQuote, Inc. Fundamentals Summary
SLQT fundamental statistics | |
---|---|
Market cap | US$548.07m |
Earnings (TTM) | -US$50.95m |
Revenue (TTM) | US$1.24b |
0.4x
P/S Ratio-10.8x
P/E RatioIs SLQT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SLQT income statement (TTM) | |
---|---|
Revenue | US$1.24b |
Cost of Revenue | US$675.52m |
Gross Profit | US$560.83m |
Other Expenses | US$611.77m |
Earnings | -US$50.95m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Sep 13, 2024
Earnings per share (EPS) | -0.30 |
Gross Margin | 45.36% |
Net Profit Margin | -4.12% |
Debt/Equity Ratio | 197.8% |
How did SLQT perform over the long term?
See historical performance and comparison